A new penumbra: transitioning from injury into repair after stroke

[1]  E. Lo.  Experimental models, neurovascular mechanisms and translational issues in stroke research , 2008, British journal of pharmacology.

[2]  J. Baron,et al.  Pathophysiology of ischaemic stroke: insights from imaging, and implications for therapy and drug discovery , 2008, British journal of pharmacology.

[3]  Hans-Christoph Diener,et al.  NXY-059 for the treatment of acute ischemic stroke. , 2007, The New England journal of medicine.

[4]  M. Chopp,et al.  Niaspan increases angiogenesis and improves functional recovery after stroke , 2007, Annals of neurology.

[5]  M. Ginsberg.  Life After Cerovive: A Personal Perspective on Ischemic Neuroprotection in the Post–NXY-059 Era , 2007, Stroke.

[6]  M. Fisher,et al.  Future of neuroprotection for acute stroke: In the aftermath of the SAINT trials , 2007, Annals of neurology.

[7]  E. Lo,et al.  Neurovascular Proteases in Brain Injury, Hemorrhage and Remodeling After Stroke , 2007, Stroke.

[8]  J. S. King,et al.  Preconditioning Reprograms the Response to Ischemic Injury and Primes the Emergence of Unique Endogenous Neuroprotective Phenotypes: A Speculative Synthesis , 2007, Stroke.

[9]  M. Chopp,et al.  Neurogenesis, Angiogenesis, and MRI Indices of Functional Recovery From Stroke , 2007, Stroke.

[10]  G. Gobbel,et al.  Molecular Mechanisms of DNA Damage and Repair in Ischemic Neuronal Injury , 2007 .

[11]  Scott Hamilton,et al.  Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study , 2006, Annals of neurology.

[12]  T. Herdegen,et al.  The bright side of JNKs—Multitalented mediators in neuronal sprouting, brain development and nerve fiber regeneration , 2006, Progress in Neurobiology.

[13]  Phillip B. Jones,et al.  Vasoconstrictive Neurovascular Coupling during Focal Ischemic Depolarizations , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[14]  M. Ushio-Fukai.  Redox signaling in angiogenesis: role of NADPH oxidase. , 2006, Cardiovascular research.

[15]  S. Rhee,et al.  H2O2, a Necessary Evil for Cell Signaling , 2006, Science.

[16]  J. Koziol.  NXY-059 for acute ischemic stroke. , 2006, The New England journal of medicine.

[17]  Steven Warach,et al.  Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): Evidence of Safety and Efficacy 3 to 9 Hours After Stroke Onset , 2006, Stroke.

[18]  B. Rosen,et al.  Role of matrix metalloproteinases in delayed cortical responses after stroke , 2006, Nature Medicine.

[19]  E. Lo,et al.  Involvement of Matrix Metalloproteinase in Neuroblast Cell Migration from the Subventricular Zone after Stroke , 2006, The Journal of Neuroscience.

[20]  S. Rhee.  Cell signaling. H2O2, a necessary evil for cell signaling. , 2006, Science.

[21]  N. Bazan,et al.  Brain Response to Injury and Neurodegeneration , 2005 .

[22]  N. Bazan,et al.  Brain response to injury and neurodegeneration: endogenous neuroprotective signaling. , 2005, Annals of the New York Academy of Sciences.

[23]  Yanqin Gao,et al.  Neuroprotection against Focal Ischemic Brain Injury by Inhibition of c-Jun N-Terminal Kinase and Attenuation of the Mitochondrial Apoptosis-Signaling Pathway , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[24]  G. Rosenberg,et al.  Multiple roles for MMPs and TIMPs in cerebral ischemia , 2005, Glia.

[25]  N. Hardingham,et al.  Nuclear Ca2+ and the cAMP Response Element-Binding Protein Family Mediate a Late Phase of Activity-Dependent Neuroprotection , 2005, The Journal of Neuroscience.

[26]  M. Moskowitz,et al.  Exciting, radical, suicidal: how brain cells die after stroke. , 2005, Stroke.

[27]  S. Warach,et al.  The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A Phase II MRI-Based 9-Hour Window Acute Stroke Thrombolysis Trial With Intravenous Desmoteplase , 2005, Stroke.

[28]  K. Furie,et al.  Mechanisms of Hemorrhagic Transformation After Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke , 2004, Stroke.

[29]  A. Buchan,et al.  Lost in translation: taking neuroprotection from animal models to clinical trials , 2004, Experimental Neurology.

[30]  Niaz Ahmed,et al.  Neuroprotection in Cerebral Ischaemia: Facts and Fancies – The Need for New Approaches , 2003, Cerebrovascular Diseases.

[31]  K. Arai,et al.  Lipoprotein receptor–mediated induction of matrix metalloproteinase by tissue plasminogen activator , 2003, Nature Medicine.

[32]  A. Vercelli,et al.  A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia , 2003, Nature Medicine.

[33]  Ulrich Dirnagl,et al.  Ischemic tolerance and endogenous neuroprotection , 2003, Trends in Neurosciences.

[34]  Eng H. Lo,et al.  Neurological diseases: Mechanisms, challenges and opportunities in stroke , 2003, Nature Reviews Neuroscience.

[35]  G. Donnan,et al.  Section Editors: Measurement of the Ischemic Penumbra with Mri: It's about Time Controversies in Stroke , 2022 .

[36]  C. Ikonomidou,et al.  Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? , 2002, The Lancet Neurology.

[37]  O. Lindvall,et al.  N‐methyl‐d‐aspartate receptor‐mediated increase of neurogenesis in adult rat dentate gyrus following stroke , 2001, The European journal of neuroscience.

[38]  J. Baron,et al.  Mapping the ischaemic penumbra with PET: a new approach. , 2001, Brain : a journal of neurology.

[39]  C. Ikonomidou,et al.  Neuronal death enhanced by N-methyl-D-aspartate antagonists. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[40]  W D Heiss,et al.  Ischemic Penumbra: Evidence From Functional Imaging in Man , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[41]  F. Sharp,et al.  Multiple Molecular Penumbras after Focal Cerebral Ischemia , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[42]  Gary Duckwiler,et al.  Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging , 2000, Annals of neurology.

[43]  G. Schlaug,et al.  The ischemic penumbra: operationally defined by diffusion and perfusion MRI. , 1999, Neurology.

[44]  M. Moskowitz,et al.  Pathobiology of ischaemic stroke: an integrated view , 1999, Trends in Neurosciences.

[45]  M. Dragunow,et al.  Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective , 1999, Nature Medicine.

[46]  M. Moskowitz,et al.  Temporal correlation mapping analysis of the hemodynamic penumbra in mutant mice deficient in endothelial nitric oxide synthase gene expression. , 1996, Stroke.

[47]  M. Moskowitz,et al.  Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. , 1994, Science.

[48]  M. Moskowitz,et al.  Nitric Oxide Synthase Inhibition and Cerebrovascular Regulation , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[49]  M. Ginsberg.  Local metabolic responses to cerebral ischemia. , 1990, Cerebrovascular and brain metabolism reviews.

[50]  M. Raichle,et al.  Physiological responses to focal cerebral ischemia in humans , 1984, Annals of neurology.

[51]  W D Heiss,et al.  Flow thresholds of functional and morphological damage of brain tissue. , 1983, Stroke.

[52]  N M Branston,et al.  Cortical Evoked Potential and Extracellular K+ and H+ at Critical Levels of Brain Ischemia , 1977, Stroke.

[53]  Ruth E. Hartley,et al.  An integrated view. , 1973 .

[54]  H. Redkey,et al.  A new approach. , 1967, Rehabilitation record.